Cargando…
Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be sign...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865580/ https://www.ncbi.nlm.nih.gov/pubmed/33503932 http://dx.doi.org/10.3390/cancers13030445 |
_version_ | 1783647879659782144 |
---|---|
author | Kang, Chang Moo Suh, Kyung-Suk Yi, Nam-Joon Hong, Tae Ho Park, Sang Jae Ahn, Keun Soo Hayashi, Hiroki Choi, Sae Byeol Jeong, Chi-Young Takahara, Takeshi Shiozaki, Shigehiro Roh, Young Hoon Yu, Hee Chul Fukumoto, Takumi Matsuyama, Ryusei Naoki, Uyama Hashida, Kazuki Seo, Hyung Il Okabayashi, Takehiro Kitajima, Tomoo SATOI, Sohei Nagano, Hiroaki Kim, Hongbeom Taira, Kaoru Kubo, Shoji Choi, Dong Wook |
author_facet | Kang, Chang Moo Suh, Kyung-Suk Yi, Nam-Joon Hong, Tae Ho Park, Sang Jae Ahn, Keun Soo Hayashi, Hiroki Choi, Sae Byeol Jeong, Chi-Young Takahara, Takeshi Shiozaki, Shigehiro Roh, Young Hoon Yu, Hee Chul Fukumoto, Takumi Matsuyama, Ryusei Naoki, Uyama Hashida, Kazuki Seo, Hyung Il Okabayashi, Takehiro Kitajima, Tomoo SATOI, Sohei Nagano, Hiroaki Kim, Hongbeom Taira, Kaoru Kubo, Shoji Choi, Dong Wook |
author_sort | Kang, Chang Moo |
collection | PubMed |
description | SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be significantly associated with poor survival outcomes. However, the oncologic value of lymph node dissection in resected IHCC is still controversial. According to the present Korea–Japan international collaborative study, it was found that surgical retrieval of more than four lymph nodes (≥4 LNs) could improve survival outcome in resected IHCC with LNM. Based on preoperatively detectable parameters, a nomogram was established to predict LNM to suggest tailored intraoperative LN management in patients with IHCC. Further prospective research is needed to validate the present surgical strategy in resected IHCC. ABSTRACT: Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), p < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), p < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), p = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed p = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC. |
format | Online Article Text |
id | pubmed-7865580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78655802021-02-07 Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study Kang, Chang Moo Suh, Kyung-Suk Yi, Nam-Joon Hong, Tae Ho Park, Sang Jae Ahn, Keun Soo Hayashi, Hiroki Choi, Sae Byeol Jeong, Chi-Young Takahara, Takeshi Shiozaki, Shigehiro Roh, Young Hoon Yu, Hee Chul Fukumoto, Takumi Matsuyama, Ryusei Naoki, Uyama Hashida, Kazuki Seo, Hyung Il Okabayashi, Takehiro Kitajima, Tomoo SATOI, Sohei Nagano, Hiroaki Kim, Hongbeom Taira, Kaoru Kubo, Shoji Choi, Dong Wook Cancers (Basel) Article SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be significantly associated with poor survival outcomes. However, the oncologic value of lymph node dissection in resected IHCC is still controversial. According to the present Korea–Japan international collaborative study, it was found that surgical retrieval of more than four lymph nodes (≥4 LNs) could improve survival outcome in resected IHCC with LNM. Based on preoperatively detectable parameters, a nomogram was established to predict LNM to suggest tailored intraoperative LN management in patients with IHCC. Further prospective research is needed to validate the present surgical strategy in resected IHCC. ABSTRACT: Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), p < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), p < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), p = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed p = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC. MDPI 2021-01-25 /pmc/articles/PMC7865580/ /pubmed/33503932 http://dx.doi.org/10.3390/cancers13030445 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kang, Chang Moo Suh, Kyung-Suk Yi, Nam-Joon Hong, Tae Ho Park, Sang Jae Ahn, Keun Soo Hayashi, Hiroki Choi, Sae Byeol Jeong, Chi-Young Takahara, Takeshi Shiozaki, Shigehiro Roh, Young Hoon Yu, Hee Chul Fukumoto, Takumi Matsuyama, Ryusei Naoki, Uyama Hashida, Kazuki Seo, Hyung Il Okabayashi, Takehiro Kitajima, Tomoo SATOI, Sohei Nagano, Hiroaki Kim, Hongbeom Taira, Kaoru Kubo, Shoji Choi, Dong Wook Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title | Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title_full | Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title_fullStr | Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title_full_unstemmed | Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title_short | Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study |
title_sort | should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? a collaborative korea–japan study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865580/ https://www.ncbi.nlm.nih.gov/pubmed/33503932 http://dx.doi.org/10.3390/cancers13030445 |
work_keys_str_mv | AT kangchangmoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT suhkyungsuk shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT yinamjoon shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT hongtaeho shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT parksangjae shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT ahnkeunsoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT hayashihiroki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT choisaebyeol shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT jeongchiyoung shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT takaharatakeshi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT shiozakishigehiro shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT rohyounghoon shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT yuheechul shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT fukumototakumi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT matsuyamaryusei shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT naokiuyama shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT hashidakazuki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT seohyungil shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT okabayashitakehiro shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT kitajimatomoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT satoisohei shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT naganohiroaki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT kimhongbeom shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT tairakaoru shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT kuboshoji shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy AT choidongwook shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy |